The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare, called the BALANCE model, will not launch as scheduled on Jan.

Starting July 2026, Medicare will pilot the 'GLP-1 Bridge,' a temporary program allowing some retirees coverage for weight loss drugs like Wegovy and Zepbound. The initiative marks a shift from ...

Only 20% of people who are eligible for screening actually get checked. Some of this failure can be traced to persistent ...

Medicare limits access to lifesaving treatments for common illnesses, including a type of heart valve disease affecting 2.5 ...

Street medicine is rapidly expanding in the United States, but realizing its potential to improve health outcomes will ...

It's a big job to regulate the nation's largest property and casualty insurance market for homeowners, businesses, renters ...

Jamie Raskin (D-Md.), said it would enable “sweeping FISA section 702 surveillance authority to spy on American citizens’ ...

The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity ...

Participating payers reported an 11% reduction in prior authorization requirements overall, with Medicare Advantage exceeding ...

Most people reach their sixties with strong opinions about money, but one topic still blindsides even the most prepared ...

Expanding the GUIDE model’s eligibility language to include adults with intellectual and developmental disabilities offers a ...